Updated:
NextGen Capital Partners
NextGen Capital Partners is a Munich-based private equity firm investing in European life sciences companies from early stage through growth.
NextGen Capital Partners
NextGen Capital Partners is a Munich-based private equity firm investing in European life sciences companies from early stage through growth. The firm targets biotechnology, digital health, and healthcare services ventures, operating at the intersection of scientific innovation and commercial scalability. The firm's strategy spans venture and growth equity, with a focus on companies advancing therapeutics, medical devices, and digital health platforms. NextGen participates in direct equity investments and syndicated rounds, deploying capital across Germany, Switzerland, and broader Western Europe. Its investment approach emphasizes partnerships with founding scientists and management teams to bridge the gap between clinical development and market access. Operating from Munich, NextGen maintains proximity to one of Europe's densest biotech clusters. The firm's geographic concentration in Germany and neighboring life sciences hubs provides access to academic spinouts, clinical-stage assets, and regulatory pathways distinct from US-centric venture models. NextGen's structural differentiator lies in its singular focus on European life sciences venture and growth, a mandate that positions it as a specialist rather than a generalist technology investor. The firm does not operate a multi-asset-family-office structure or co-investor club, functioning instead as a dedicated investment platform for institutional and private capital seeking exposure to European healthcare innovation.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Munich, Germany
Sector focus
Frequently asked questions
What investment stages does NextGen Capital Partners target?
NextGen invests from early stage through growth, covering seed, Series A, and expansion rounds. The firm focuses on companies that have progressed beyond pure preclinical research and are advancing toward clinical validation or commercial launch.
Which sectors does NextGen Capital Partners explicitly avoid?
The firm does not invest outside life sciences — it avoids general technology, consumer, industrial, and financial services sectors. Its mandate is restricted to biotechnology, medical devices, digital health, and healthcare services.
How does NextGen source its investment opportunities?
NextGen sources opportunities through its network within European academic medical centers, biotech incubators, and research institutions, particularly in Germany and Switzerland. Proximity to Munich's life sciences cluster provides direct access to spinouts and early-stage ventures.
Does NextGen operate as a single family office or institutional fund manager?
NextGen Capital Partners operates as an institutional asset manager, not a family office. The firm manages pooled investment vehicles for external investors, focusing exclusively on European life sciences private equity.
What is NextGen's geographic investment focus?
NextGen concentrates on Germany, Switzerland, and Western Europe, leveraging Munich's position as a leading biotech hub. The firm may evaluate opportunities in Scandinavia and the United Kingdom when aligned with its therapeutic and digital health themes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: